Organization Overview
Historical Acquisition Tree
Alternative names
ibalizumab-uiyk (trogarzo) (2018)
tesamorelin (egrifta) (2010 NDA)
Cachexia (Phase 2)
Diabetes Mellitus (Phase 2)
Diabetes Mellitus, Type 2 (Phase 2)
Diabetic Retinopathy (Phase 4)
HIV Seropositivity (Phase 1)
Lipodystrophy (Phase 3)
Lung Diseases (Phase 2)
Lung Diseases, Obstructive (Phase 2)
Muscular Atrophy (Phase 2)
Pulmonary Disease, Chronic Obstructive (Phase 2)
Retinal Diseases (Phase 4)
Wasting Syndrome (Phase 2)